Application 209830
- Type
- NDA
- Sponsor
- ALKERMES INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ARISTADA INITIO KIT | ARIPIPRAZOLE LAUROXIL | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 675MG/2.4ML | Yes | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 65757-500 | ARISTADA INITIO | aripiprazole lauroxil | Alkermes, Inc. | NDA | Current |
| 65757-500 | ARISTADA INITIO | aripiprazole lauroxil | Alkermes, Inc. | NDA | Current |
| 65757-500 | ARISTADA INITIO | aripiprazole lauroxil | Alkermes, Inc. | NDA | Current |
| 65757-500 | ARISTADA INITIO | aripiprazole lauroxil | Alkermes, Inc. | NDA | Current |
| 65757-500 | ARISTADA INITIO | aripiprazole lauroxil | Alkermes, Inc. | NDA | Current |
| 65757-500 | ARISTADA INITIO | aripiprazole lauroxil | Alkermes, Inc. | NDA | Current |
| 65757-500 | ARISTADA INITIO | aripiprazole lauroxil | Alkermes, Inc. | NDA | Current |
| 65757-500 | ARISTADA INITIO | aripiprazole lauroxil | Alkermes, Inc. | NDA | Current |